• FirefoxInstall the new Firefox »
  •  Dow Up0.19% Nasdaq Up0.57%

    Pacific Biosciences of California, Inc. (PACB)

    5.59 Up 0.17(3.14%) Mar 27, 4:00PM EDT
    |After Hours : 5.55 Down 0.04 (0.72%) Mar 27, 5:36PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Pacific Biosciences of California, Inc.
    1380 Willow Road
    Menlo Park, CA 94025
    United States - Map
    Phone: 650-521-8000
    Website: http://www.pacificbiosciences.com

    Index Membership:N/A
    Full Time Employees:344

    Business Summary 

    Pacific Biosciences of California, Inc. designs, develops, manufactures, and markets an integrated platform for genetic analysis. The company provides single molecule real-time (SMRT) technology platform, which enables single molecule real-time detection of biological processes. It offers PacBio RS II high resolution genetic analyzer, an instrument that conducts, monitors, and analyzes single molecule biochemical reactions in real time. The company provides consumable products, which include sealed and packaged SMRT Cells, as well as various reagent kits, such as template preparation kits, binding kits, and sequencing kits to run the PacBio RS II. Its customers include research institutions, commercial laboratories, genome centers, clinical, government and academic institutions, genomics service providers, pharmaceutical companies, and agricultural companies. The company markets its products through a direct sales force in North America and Europe as well as primarily through distributors in Asia. The company was formerly known as Nanofluidics, Inc. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Pacific Biosciences of California, Inc.

    Corporate Governance 
    Pacific Biosciences of California, Inc.’s ISS Governance QuickScore as of Mar 1, 2015 is 7. The pillar scores are Audit: 1; Board: 9; Shareholder Rights: 6; Compensation: 6.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Dr. Michael W. Hunkapiller Ph.D., 66
    Exec. Chairman, Chief Exec. Officer, Pres and Member of Compensation Committee
    Ms. Susan K. Barnes , 61
    Chief Financial Officer and Exec. VP
    Mr. James Michael Phillips , 64
    Sr. VP of R&D
    Mr. Kevin P. Corcoran , 56
    Sr. VP of Market Devel.
    Dr. Stephen Turner Ph.D., 47
    Co-Founder and Chief Technology Officer
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders